Cardiac Pacing
16
3
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Ultrasound-Guided PECS II Block for Permanent Pacemaker Implantation
Cardiac Anodal Biphasic Pacing
BIO|STREAM.CSP Study
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node Dysfunction
AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
Immediate Electrophysiological Effects of Different Atrial Pacing Sites on P-Wave Characteristics
ECG and Echo Characteristics of BBAP
LVSP vs RVP in Patients With AV Conduction Disorders
Change of QRS Morphology and Electrophysiological Characteristics During Pacing Within the Interventricular Septum
Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
Image Location and Performance of Left Bundle Branch Pacing
Ventricular Electrical Synchronization by Stimulating Left and Right Bundle Branches Area in Pacing-indicated Patients
Optimize RV Follow-up Selective Site Pacing Clinical Trial
Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)
Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation